We identified loss-of-function mutations in the gene encoding the secreted growth factor progranulin (PGRN) as a major cause of familial frontotemporal lobar degeneration with ubiquitin and TDP-43-positive inclusions (FTLD-U). The exact role of PGRN in neurons has yet to be established, however, the loss of functional PGRN in FTLD-U implicates its essential function in neuronal survival. The identification of TDP-43 as the pathological protein, not only in patients with FTLD-U with mutations in PGRN, but also in the majority of patients with ALS and in 20-30% of pathologically confirmed Alzheimer's disease (AD) patients further suggests a role for the TDP-43 protein in a unifying neurodegenerative disease mechanism underlying these disorders. The recent identification of mutations in TDP-43 as a direct cause of neurodegeneration in sporadic and familial patients with ALS strongly supports this notion. Our working hypothesis is that the PGRN/TDP-43 axis plays a role in multiple neurodegenerative diseases including AD. In this project we will use both genetic and proteomic methods to help understand the role of PGRN and TDP-43 in AD and other neurodegenerative disorders.
The Specific Aims of this project are: 1. To determine the role of genetic variants in PGRN and TARDBP (TDP-43) in the development and presentation of AD. We will perform genetic association studies of PGRN and TARDBP in Caucasian and African/American AD case-control populations and study the effect of common genetic variability on PGRN and TDP-43 expression levels, TDP-43 pathology and disease. 2. To identify novel PGRN and TDP-43 interacting proteins using somatic brain transgenic technology. We will use somatic brain transgenic technology to express dual affinity tagged PGRN and TDP-43 proteins in the mouse brain to identify binding partners of both PGRN and TDP-43. Proteins will be identified by proteomic technologies. Subsequent studies will validate whether PGRN/TDP-43 proteins interact in human brain tissue and are altered by disease state. The proposed studies are relevant to fully appreciate the contribution of genetic variants in PGRN and TARDBP to the development and presentation of AD. Identifying the protein networks of PGRN and TDP-43 will be critical for understanding the pathways of neurodegeneration mediated by PGRN and TDP- 43 and may lead to the identification of novel therapeutic targets.

Public Health Relevance

This proposal is designed to enhance our understanding of the protein networks of PGRN and TDP-43 and to determine whether genetic factors perturbing this network may contribute to the development and presentation of Alzheimer's disease. Unveiling the genetic and molecular pathways that regulate PGRN and TDP-43 lead to novel targets that can be exploited for therapeutic actions aimed at preventing or delaying neurodegenerative diseases

National Institute of Health (NIH)
National Institute on Aging (NIA)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Mayo Clinic, Rochester
United States
Zip Code
Ma, Li; Allen, Mariet; Sakae, Nobutaka et al. (2016) Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer's disease brains. Mol Neurodegener 11:72
Tosto, Giuseppe; Bird, Thomas D; Bennett, David A et al. (2016) The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease. JAMA Neurol 73:1231-1237
Karch, Celeste M; Ezerskiy, Lubov A; Bertelsen, Sarah et al. (2016) Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One 11:e0148717
Staubo, Sara C; Aakre, Jeremiah A; Vemuri, Prashanthi et al. (2016) Mediterranean diet, micronutrients and macronutrients, and MRI measures of cortical thickness. Alzheimers Dement :
Kantarci, Kejal; Lowe, Val J; Lesnick, Timothy G et al. (2016) Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition. J Alzheimers Dis 53:547-56
Zheng, Honghua; Liu, Chia-Chen; Atagi, Yuka et al. (2016) Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation. Neurobiol Aging 42:132-41
Forrester, Sarah N; Gallo, Joseph J; Smith, Gwenn S et al. (2016) Patterns of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Risk of Dementia. Am J Geriatr Psychiatry 24:117-25
Labbé, Catherine; Heckman, Michael G; Lorenzo-Betancor, Oswaldo et al. (2016) MAPT haplotype diversity in multiple system atrophy. Parkinsonism Relat Disord 30:40-5
McCutcheon, Sarah T; Han, Dingfen; Troncoso, Juan et al. (2016) Clinicopathological correlates of depression in early Alzheimer's disease in the NACC. Int J Geriatr Psychiatry 31:1301-1311
Rodriguez-Porcel, Federico; Lowder, Lindsey; Rademakers, Rosa et al. (2016) Fulminant corticobasal degeneration: Agrypnia excitata in corticobasal syndrome. Neurology 86:1164-6

Showing the most recent 10 out of 813 publications